GET DAILY SIGNALSAVNM vs IXUS: Weighing an Active Value Tilt Against a Low-Cost International Index Fund
Key Takeaways
- Both funds offer broad exposure to non-U.S. developed and emerging market equities, but AVNM is an actively managed fund-of-funds with a value and profitability tilt, while IXUS is a passive, market-capitalization-weighted index tracker.
- The cost gap is meaningful: AVNM carries a net expense ratio of 0.31%, versus 0.07% for IXUS.
- Diversification profiles differ sharply: IXUS holds roughly 4,174 individual securities, whereas AVNM holds eight underlying Avantis exchange-traded funds (ETFs) that collectively span thousands of stocks.
- Factor positioning diverges: AVNM underweights technology and overweights financials, materials, and energy relative to IXUS, which has heavier exposure to large-cap semiconductors.
- Liquidity and scale strongly favor IXUS, which is a far larger and more established vehicle than the 2023-launched AVNM.
- Tickeron AI Verdict: IXUS is the favored ticker of the two, based on cost efficiency, diversification breadth, liquidity, and structural simplicity.
Why International Exposure Matters Right Now
International equity exposure has become a central diversification question for U.S.-based investors, particularly as relative valuations outside the United States remain attractive and currency and policy dynamics evolve. Comparing AVNM and IXUS is instructive because these funds pursue the same broad goal—owning non-U.S. developed and emerging market stocks—through fundamentally different methods. One is an actively managed, factor-tilted fund-of-funds; the other is a low-cost, index-based core holding. Investors weighing these two vehicles are effectively choosing between a rules-based value approach and a broad, market-cap-weighted benchmark strategy.
A Closer Look at AVNM
AVNM is an actively managed fund-of-funds that invests primarily in other Avantis ETFs to gain exposure to non-U.S. developed and emerging market equities. Launched in June 2023 by Avantis Investors, a unit of American Century Investments, the fund pursues long-term capital appreciation by overweighting securities with higher expected returns, emphasizing value and profitability characteristics while retaining the diversification benefits of broad indexing. I also checked this using Tickeron’s AI Screener to see how the fund’s holdings stack up against peers in the international equity space.
Structurally, AVNM holds just eight underlying ETFs. Its largest positions are the AVDE Avantis International Equity ETF (roughly 40%), the AVIV Avantis International Large Cap Value ETF (about 20%), and the AVEM Avantis Emerging Markets Equity ETF (about 18%), supplemented by emerging markets value (AVES), international small-cap value (AVDV), and smaller emerging and international small-cap sleeves. The fund's net expense ratio is 0.31%.
Sector-wise, AVNM leans toward financials (roughly 24%), industrials (about 16%), technology (around 11-14%), basic materials (10-11%), and energy (7-8%). Its factor tilt produces an underweight to mega-cap technology and an overweight to value-oriented sectors compared with a plain market-cap benchmark.
A Closer Look at IXUS
IXUS is a passive index fund managed by BlackRock's iShares that seeks to track the MSCI ACWI ex USA Investable Market Index, a free-float-adjusted, market-capitalization-weighted benchmark covering large-, mid-, and small-cap equities across developed and emerging markets outside the United States. Incepted in October 2012, it is one of the most established low-cost international core holdings available.
The fund holds roughly 4,174 securities and charges a net expense ratio of just 0.07%. Its top positions are dominated by global large caps, including Taiwan Semiconductor Manufacturing (TSM), Samsung Electronics, ASML Holding (ASML), SK hynix, and HSBC Holdings, reflecting the index's heavy semiconductor and financials weighting. Sector allocation is led by financial services (around 23%), industrials (15-16%), and technology (15-19%), with meaningful consumer discretionary, healthcare, and materials exposure. Geographically, Japan is the largest country weight, followed by Taiwan, the United Kingdom, Canada, and China.
Current Industry and Thematic Context
Both funds operate in the same macro environment. International equities have benefited in recent market cycles from relatively lower valuations, a weaker U.S. dollar at times, and strong earnings from Asian semiconductor and technology leaders tied to artificial intelligence investment. Financials and value-oriented sectors have also drawn capital as investors seek yield and cheaper cyclical exposure outside the United States. At the same time, risks include China's uneven economic recovery, geopolitical tensions, currency volatility, and sensitivity of export-heavy markets such as Japan, Taiwan, and South Korea to global trade policy.
Performance and Positioning Side by Side
Over recent months and recent market cycles, the two funds have generally moved in tandem given their shared international equity mandate, but their factor differences have produced divergence at the margin. IXUS, with its larger technology and mega-cap semiconductor exposure, has tended to capture more upside during growth-led rallies, while AVNM's value, materials, and energy tilts have provided differentiated relative positioning during cyclical and commodity-driven rotations. On a volatility basis, AVNM's smaller size and factor concentration can introduce modest tracking variability versus its benchmark, whereas IXUS more closely mirrors broad international market behavior. From a cost-adjusted standpoint, the 0.31% versus 0.07% fee differential is a persistent structural headwind for AVNM over long horizons. I also checked this using Tickeron’s AI Trend Prediction Engine to gauge recent momentum patterns between the two.
How I Use Tickeron’s AI Screener for ETF Comparisons
When I evaluate competing international equity funds like these, Tickeron’s AI Screener helps me quickly filter on relative strength, momentum, and risk metrics across thousands of securities. The tool lets me apply customizable technical and fundamental screens to surface how each fund has behaved in different market regimes, which adds a useful layer to the structural comparison above. It is the kind of resource I return to when building or refining a diversified international sleeve.
Tickeron AI Verdict
On a structural, cost-adjusted basis, Tickeron's AI would likely favor IXUS over AVNM for a broad international allocation. The decisive factors are IXUS's materially lower expense ratio (0.07% versus 0.31%), its vastly broader direct diversification across more than 4,000 securities, deeper liquidity, and longer operational track record. While AVNM's value and profitability tilt offers a potentially compelling factor exposure that could outperform in value-led or cyclical environments, that expected-return edge is probabilistic and must overcome a persistent fee disadvantage and lower structural simplicity. IXUS therefore presents the more efficient, lower-friction core vehicle for most investors seeking diversified international equity exposure.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
IXUS in upward trend: price may jump up because it broke its lower Bollinger Band on November 05, 2026
IXUS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 32 of 34 cases where IXUS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on IXUS as a result. In 66 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for IXUS just turned positive on November 10, 2026. Looking at past instances where IXUS's MACD turned positive, the stock continued to rise in 40 of 45 cases over the following month. The odds of a continued upward trend are 89%.
Following a +3.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where IXUS advanced for three days, in 285 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 51 of 58 cases where IXUS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for IXUS entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
Advertisement